One has to wonder.... why not at some orthopedic conference? Should be interesting, nonetheless.
SHANGHAI, China and CUPERTINO, Calif., Dec. 22, 2015 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc.(CBMG) , a biomedicine firm engaged in the development of effective stem cell therapies for degenerative diseases and immunotherapies for cancer, today announced a scheduled presentation to release 48-week clinical data from the Phase IIb trial of its ReJoin® human adipose-derived mesenchymal progenitor cell (haMPC) therapy for Knee Osteoarthritis (KOA) at the 8th Annual BioTech Showcase investor conference to be held in San Francisco, CA January 11-13, 2016.
Conference: 8th Annual BioTech Showcase 2016
Date: Tuesday, January 12, 2016
Time: 10:00 AM PDT
Title: Alteration of Knee Osteoarthritis, ReJoin® Phase IIb One Year Follow Up Results
Location: Track C - Mission II, 4th Floor, Parc 55, Union Square, 55 Cyril Magnin Street, San Francisco, CA
Presenter: Wei (William) Cao, PhD, BM, Chief Executive Officer
About Cellular Biomedicine Group(CBMG)
Cellular Biomedicine Group, Inc. (CBMG) develops proprietary cell therapies for the treatment of certain degenerative and cancerous diseases. Our developmental stem cell and Immuno-Oncology projects are the result of research and development by scientists and doctors from China and the United States. Our flagship GMP facility in China, consisting of six independent cell production lines, is designed, certified and managed according to U.S. standards. To learn more about CBMG, please visit:
I think Cytori's strategy is to be the first autologous ADRC stem cell company to get FDA approval for one or more specific applications. When the copycats get their approval, Cytori will sue them for patent infringement and if they win will get a royalty from all those who follow. By openly helping the R&D effort of our competitors by offering Celase for sale, Cytori believes these labs doing research using ADRCs will produce better results. With better results, money will be found to go through the FDA faster. Once they get FDA approval, they should already know about Cytori's patents because they have been using Celase to obtain their cells. I believe it is one of the smartest things Cytori has ever done even if it doesn't work.
It would be similar to me selling books and learning software to students so they will be fully capable of paying my social security benefits.